BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved ...

The particle size distribution of QVAR was measured using the Andersen cascade impactor (series 20-800 Mark II, Ecomesure, Janvry, France) operating at 28.3 L/min. The endotracheal tube was connected ...

First and Only Breath-Actuated Aerosol Inhaled Corticosteroid in the United States Designed to Help Eliminate the Need for Hand-Breath Coordination JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical ...

Objective: The aim of this study was to demonstrate that a new non-extra-fine metered-dose inhaler formulation of beclomethasone (beclomethasone dipropionate) containing hydrofluoroalkane (HFA) ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the use of QVAR® (beclomethasone dipropionate ...

Additional results from a Phase I study that evaluated the pharmacokinetics, safety and tolerability of QNAZE™ HFA, showed that the systemic exposure following administration of the treatment (up to ...

A total of 498 patients entered the run-in phase, of whom 473 received randomised treatment and 443 were included in the ITT analysis [293 (66.1%) to beclomethasone ...

BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has tentatively ...

Amneal Pharmaceuticals Inc, a global biopharmaceutical company headquartered in Bridgewater, announced that the US Food and Drug Administration (FDA) has tentatively approved the company’s Abbreviated ...

(MENAFN- GlobeNewsWire - Nasdaq) Company's first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines segment BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE ...